Cargando…
Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery
Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunitie...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537003/ https://www.ncbi.nlm.nih.gov/pubmed/37765069 http://dx.doi.org/10.3390/ph16091259 |
_version_ | 1785113000942764032 |
---|---|
author | Han, Ri Yoon, Hongryul Kim, Gahee Lee, Hyundo Lee, Yoonji |
author_facet | Han, Ri Yoon, Hongryul Kim, Gahee Lee, Hyundo Lee, Yoonji |
author_sort | Han, Ri |
collection | PubMed |
description | Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI’s growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts. |
format | Online Article Text |
id | pubmed-10537003 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105370032023-09-29 Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery Han, Ri Yoon, Hongryul Kim, Gahee Lee, Hyundo Lee, Yoonji Pharmaceuticals (Basel) Review Artificial intelligence (AI) has permeated various sectors, including the pharmaceutical industry and research, where it has been utilized to efficiently identify new chemical entities with desirable properties. The application of AI algorithms to drug discovery presents both remarkable opportunities and challenges. This review article focuses on the transformative role of AI in medicinal chemistry. We delve into the applications of machine learning and deep learning techniques in drug screening and design, discussing their potential to expedite the early drug discovery process. In particular, we provide a comprehensive overview of the use of AI algorithms in predicting protein structures, drug–target interactions, and molecular properties such as drug toxicity. While AI has accelerated the drug discovery process, data quality issues and technological constraints remain challenges. Nonetheless, new relationships and methods have been unveiled, demonstrating AI’s expanding potential in predicting and understanding drug interactions and properties. For its full potential to be realized, interdisciplinary collaboration is essential. This review underscores AI’s growing influence on the future trajectory of medicinal chemistry and stresses the importance of ongoing synergies between computational and domain experts. MDPI 2023-09-06 /pmc/articles/PMC10537003/ /pubmed/37765069 http://dx.doi.org/10.3390/ph16091259 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Han, Ri Yoon, Hongryul Kim, Gahee Lee, Hyundo Lee, Yoonji Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery |
title | Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery |
title_full | Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery |
title_fullStr | Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery |
title_full_unstemmed | Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery |
title_short | Revolutionizing Medicinal Chemistry: The Application of Artificial Intelligence (AI) in Early Drug Discovery |
title_sort | revolutionizing medicinal chemistry: the application of artificial intelligence (ai) in early drug discovery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10537003/ https://www.ncbi.nlm.nih.gov/pubmed/37765069 http://dx.doi.org/10.3390/ph16091259 |
work_keys_str_mv | AT hanri revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery AT yoonhongryul revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery AT kimgahee revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery AT leehyundo revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery AT leeyoonji revolutionizingmedicinalchemistrytheapplicationofartificialintelligenceaiinearlydrugdiscovery |